Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease-Reference-Cited by-同舟云学术

Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease

Published:2014-01 Issue:1 Volume:85 Page:103-111
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Posada-Ayala Maria,Zubiri Irene,Martin-Lorenzo Marta,Sanz-Maroto Aroa,Molero Dolores,Gonzalez-Calero Laura,Fernandez-Fernandez Beatriz,de la Cuesta Fernando,Laborde Carlos M.,Barderas Maria G.,Ortiz Alberto,Vivanco Fernando,Alvarez-Llamas Gloria

Publisher

Elsevier BV

Subject

Nephrology

Reference22 articles.

1. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality;Peralta;JAMA,2011

2. The sudden demise of dual renin-angiotensin system blockade or the soft science of the surrogate end point;Messerli;J Am Coll Cardiol,2009

3. Biomarkers in chronic kidney disease: a review;Fassett;Kidney Int,2011

4. Application of proteomic analysis to the study of renal diseases;Smith;Nat Rev Nephrol,2009

5. Metabolomics in the study of kidney diseases;Weiss;Nat Rev Nephrol,2012

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics and molecular dynamics unveil the therapeutic potential of epalrestat in diabetic nephropathy;International Immunopharmacology;2024-10

2. Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition;Kidney International;2024-06

3. A New Murine Undernutrition Model Based on Complementary Feeding of Undernourished Children Causes Damage to the Morphofunctional Intestinal Epithelium Barrier;The Journal of Nutrition;2024-04

4. Prevalence of Metabolic Syndrome among middle-aged patients and its association with chronic kidney disease: A Cross-sectional study;2024-03-04

5. Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insights;Frontiers of Medicine;2024-02